2023-05-10

New BD survey finds nearly half of women unaware of STI treatment options

FiercePharma

Nearly half of women don’t know what treatment options are available for STIs – we need better education.

FiercePharma reports on new Harris Poll findings revealing extreme knowledge gaps in women’s understanding of STIs, testing and treatment options.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Cervical Cancer | Webinars & Videos
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?